XBiotech's Vilamakitug Clears FDA IND Review for Phase II AxSpA Trial
The V-SPINE study opens U.S. enrollment for a condition with significant unmet need, signaling continued biotech intere…
The V-SPINE study opens U.S. enrollment for a condition with significant unmet need, signaling continued biotech intere…
Bitopertin also posts sustained PPIX reductions and improved light tolerance in EPP extension trial, broadening Disc Me…
The peer-reviewed findings position continuous EEG monitoring as a clinical decision-making tool in ICU settings — with…
Responder analysis from the Phase 2 VIBRANT trial will detail the proportion of CRSwNP patients achieving clinically me…
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
An R&D Spotlight planned for late summer is expected to outline next-stage development milestones for the investigation…